Company Profiles

driven by the PitchBook Platform

Tocagen

Description

Developer of cancer-selective gene therapies designed to activate a patient's immune system against their own cancer from within. The company's gene therapy technology deliver therapeutic genes into the DNA of cancer cells and activate a patient's immune system to fight against their cancer from within, enabling cancer patients to safely and effectively control the disease.

2007

Founded

IPO REG.

Status

51-200

Employees

IPO

Latest Deal Type

$86.2M

Latest Deal Amount

$124M

Total Amount Raised

Description

Developer of cancer-selective gene therapies designed to activate a patient's immune system against their own cancer from within. The company's gene therapy technology deliver therapeutic genes into the DNA of cancer cells and activate a patient's immune system to fight against their cancer from within, enabling cancer patients to safely and effectively control the disease.

Website:

www.tocagen.com

Ownership Status

In IPO registration

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Other Pharmaceuticals and Biotechnology

Primary Office

3030 Bunker Hill Street Suite 230 San Diego, CA 92109United States +1 (858) 412-8400
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Tocagen's full profile, request a free trial.

Tocagen Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Tocagen Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Tocagen Investors (6)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Accelerate Brain Cancer CureOther000 0000000 0000
BiobritVenture CapitalMinority000 0000000 0000
Individual InvestorAngel (individual)Minority000 0000000 0000
National Brain Tumor SocietyCorporation000 0000000 0000
The American Brain Tumor AssociationOther000 0000000 0000
Accelerate Brain Cancer Cure Other
Biobrit Venture Capital
Individual Investor Angel (individual)
National Brain Tumor Society Corporation
The American Brain Tumor Association Other

Tocagen Executive Team (12)

NameTitleBoard
Seat
Contact
Info
Martin DuvallChief Executive Officer & Board Member
Harry Gruber MDCo-Founder, Board Member & President, Research & Development
Mark FolettaChief Financial Officer & Executive Vice President
Ching-I ChenDirector, Process Development and Manufacturing
Douglas Jolly Ph.DExecutive Vice President of Research & Pharmaceutical Development and Co-Founder
Martin Duvall Chief Executive Officer & Board Member
Harry Gruber MD Co-Founder, Board Member & President, Research & Development
Mark Foletta Chief Financial Officer & Executive Vice President
Ching-I Chen Director, Process Development and Manufacturing
Douglas Jolly Ph.D Executive Vice President of Research & Pharmaceutical Development and Co-Founder

Tocagen Board Members (9)

NameRepresentingRoleSinceContact
Info
David Parkinson MDSelfBoard Member000 0000
Dennis Berman JDTocagenCo-Founder, Board Member and Executive Vice President, Corporate Development000 0000
Faheem HasnainTocagenBoard Member000 0000
Franklin BergerSelfBoard Member000 0000
Harry Gruber MDTocagenCo-Founder, Board Member & President, Research & Development000 0000
David Parkinson MD Board Member Self
Dennis Berman JD Co-Founder, Board Member and Executive Vice President, Corporate Development Tocagen
Faheem Hasnain Board Member Tocagen
Franklin Berger Board Member Self
Harry Gruber MD Co-Founder, Board Member & President, Research & Development Tocagen
Request full access to PitchBook